AI-generated summary
The authors report a randomized, double-blind trial of 101 children with severe chemotherapy-induced oral mucositis, comparing laser photobiomodulation with sham treatment. On day 7, 93.7% of the laser group versus 72% of the sham group had mucositis below grade 3, and pain scores were lower in the laser group. The authors describe the treatment as safe, feasible and effective.
- Participants
- 101
- Who or what was studied
- Children with chemotherapy-induced severe oral mucositis (WHO grade above 2) receiving pediatric oncology care in eight Italian hospitals
- Limits stated in the abstract
- The abstract does not report the laser wavelength, and the reduction in analgesic use was not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Laser, Randomized controlled trial, GRADE, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.